Bill Snyder

July 24, 2014

VU’s technology transfer efforts gain steam

Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year.

By Bill Snyder

July 24, 2014

Team effort boosts study of tachycardia syndrome

Vanderbilt University’s Satish Raj, M.D., MSCI, was very busy — and very visible — at the Dysautonomia International Conference in Washington, D.C., earlier this month.

By Bill Snyder

July 24, 2014

Colon cancer’s protein signatures identified

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.

By Bill Snyder

July 17, 2014

Breast tissue growth protein may promote cancer: study

A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found.

By Bill Snyder

July 10, 2014

VU, Celgene announce research partnership

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.

By Bill Snyder

June 26, 2014

Awards recognize commitment, dedication to service

Credo and Five Pillar Leader Award winners were announced Tuesday during the Summer 2014 Clinical Enterprise Leadership Assembly at Langford Auditorium.